Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review

This systematic review aimed to evaluate the proportion of primary and secondary endpoints in hematopoietic stem cell transplant (HSCT) phase III randomized clinical trials (RCTs) and analyze their trends in time and study sponsorship status. The Chi-square test and logistic regression analyses were...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Moazzam Shahzad, Muhammad Fareed Khalid, Muhammad Kashif Amin, Mohammad Ammad-Ud-Din, Usman Ilyas, Ali H. Mushtaq, Atif Butt, Iqra Anwar, Sibgha Gull Chaudhary, Nausheen Ahmed, Leyla Shune, Anurag K. Singh, Sunil H. Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wolters Kluwer Medknow Publications 2024-04-01
Schriftenreihe:	Hematology/Oncology and Stem Cell Therapy
Schlagworte:	primary endpoint secondary endpoint phase iii randomized clinical trial hematopoietic stem cell transplantation outcome
Online-Zugang:	https://journals.lww.com/10.56875/2589-0646.1118
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!